These investigators have reviewed the various scores available to assess cardiovascular disease (CVD) risk in patients with type 2 diabetes. The performance of the various CVD risk scores differed across populations. Little evidence supports the view that risk scores developed in individuals with type 2 diabetes are more accurate than those developed in the general population. Overall, CVD risk scores rank individuals reasonably well and therefore these are considered as useful tools in the management of diabetes. The authors suggested that the use of CVD risk scores capable of quantifying the elements of risk which are modifiable could be an interesting strategy that may also motivate patients to change.